Article info

Short report
Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide

Authors

  • Tatsuhiko Naito Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Wataru Satake Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan PubMed articlesGoogle scholar articles
  • Pei-Chieng Cha Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan Department of Genomic Medicine, Research Institute, National Cerebral and Cardiovascular Center, Suita, Japan PubMed articlesGoogle scholar articles
  • Kazuhiro Kobayashi Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan PubMed articlesGoogle scholar articles
  • Miho Murata Department of Neurology, NCNP Hospital, Kodaira, Japan PubMed articlesGoogle scholar articles
  • Tatsushi Toda Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Wataru Satake, Neurology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; satake{at}m.u-tokyo.ac.jp; Professor Tatsushi Toda; toda{at}m.u-tokyo.ac.jp
View Full Text

Citation

Naito T, Satake W, Cha P, et al
Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide

Publication history

  • Received December 24, 2021
  • Accepted January 31, 2022
  • First published March 9, 2022.
Online issue publication 
April 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.